Literature DB >> 10433618

Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers.

K C Halling1, A J French, S K McDonnell, L J Burgart, D J Schaid, B J Peterson, L Moon-Tasson, M R Mahoney, D J Sargent, M J O'Connell, T E Witzig, G H Farr, R M Goldberg, S N Thibodeau.   

Abstract

BACKGROUND: Microsatellite instability (MSI) and allelic imbalance involving chromosome arms 5q, 8p, 17p, and 18q are genetic alterations commonly found in colorectal cancer. We investigated whether the presence or absence of these genetic alterations would allow stratification of patients with Astler-Coller stage B2 or C colorectal cancer into favorable and unfavorable prognostic groups.
METHODS: Tumors from 508 patients were evaluated for MSI and allelic imbalance by use of 11 microsatellite markers located on chromosome arms 5q, 8p, 15q, 17p, and 18q. Genetic alterations involving each of these markers were examined for associations with survival and disease recurrence. All P values are two-sided.
RESULTS: In univariate analyses, high MSI (MSI-H), i.e., MSI at 30% or more of the loci examined, was associated with improved survival (P =.02) and time to recurrence (P =.01). The group of patients whose tumors exhibited allelic imbalance at chromosome 8p had decreased survival (P =.02) and time to recurrence (P =.004). No statistically significant associations with survival or time to recurrence were observed for markers on chromosome arms 5q, 15q, 17p, or 18q. In multivariate analyses, MSI-H was an independent predictor of improved survival (hazard ratio [HR] = 0.51; 95% confidence interval [CI] = 0.31-0.82; P =.006) and time to recurrence (HR = 0.42; 95% CI = 0.24-0.74; P =.003), and 8p allelic imbalance was an independent predictor of decreased survival (HR = 1.89; 95% CI = 1.25-2.83; P =. 002) and time to recurrence (HR = 2.07; 95% CI = 1.32-3.25; P =.002).
CONCLUSIONS: Patients whose tumors exhibited MSI-H had a favorable prognosis, whereas those with 8p allelic imbalance had a poor prognosis; both alterations served as independent prognostic factors. To our knowledge, this is the first report of an association between 8p allelic imbalance and survival in patients with colorectal cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10433618     DOI: 10.1093/jnci/91.15.1295

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  96 in total

1.  Microsatellite instability in colorectal cancer: prognostic, predictive or both?

Authors:  Marius van Rijnsoever; Hany Elsaleh; Barry Iacopetta
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

2.  Microsatellite instability testing in Korean patients with colorectal cancer.

Authors:  Jung Ryul Oh; Duck-Woo Kim; Hye Seung Lee; Hee Eun Lee; Sung Min Lee; Je-Ho Jang; Sung-Bum Kang; Ja-Lok Ku; Seung-Yong Jeong; Jae-Gahb Park
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

3.  Microsatellite instability and the clinicopathological features of sporadic colorectal cancer.

Authors:  R Ward; A Meagher; I Tomlinson; T O'Connor; M Norrie; R Wu; N Hawkins
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

4.  Association between recurrent metastasis from stage II and III primary colorectal tumors and moderate microsatellite instability.

Authors:  Melissa Garcia; Chan Choi; Hyeong-Rok Kim; Yahya Daoud; Yuji Toiyama; Masanobu Takahashi; Ajay Goel; C Richard Boland; Minoru Koi
Journal:  Gastroenterology       Date:  2012-03-27       Impact factor: 22.682

5.  Prognostic factors in node-negative colorectal cancer: a retrospective study from a prospective database.

Authors:  Gregoire Desolneux; Pascal Burtin; Emilie Lermite; Roberto Bergamaschi; Antoine Hamy; Jean Pierre Arnaud
Journal:  Int J Colorectal Dis       Date:  2010-04-20       Impact factor: 2.571

6.  Inherited colorectal cancer syndromes.

Authors:  Robert Gryfe
Journal:  Clin Colon Rectal Surg       Date:  2009-11

7.  High-resolution analysis of DNA copy number alterations in rectal cancer: correlation with metastasis, survival, and mRNA expression.

Authors:  Jérôme Doyen; Eric Letouzé; Laetitia Marisa; Aurélien de Reyniès; Gérard Milano; Marie-Christine Etienne-Grimaldi; Sylviane Olschwang; Jochen Gaedcke; Michael Ghadimi; Jean-Pierre Gérard
Journal:  Strahlenther Onkol       Date:  2014-04-26       Impact factor: 3.621

8.  Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis.

Authors:  Lian-Hai Zhang; Lun-Xiu Qin; Zeng-Chen Ma; Sheng-Long Ye; Yin-Kun Liu; Qing-Hai Ye; Xin Wu; Wei Huang; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2003-05-07       Impact factor: 4.553

9.  Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening.

Authors:  Jenny N Poynter; Kimberly D Siegmund; Daniel J Weisenberger; Tiffany I Long; Stephen N Thibodeau; Noralane Lindor; Joanne Young; Mark A Jenkins; John L Hopper; John A Baron; Dan Buchanan; Graham Casey; A Joan Levine; Loïc Le Marchand; Steven Gallinger; Bharati Bapat; John D Potter; Polly A Newcomb; Robert W Haile; Peter W Laird
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

10.  Adjuvant Chemotherapy for Stage II Colon Cancer: The Role of Molecular Markers in Choosing Therapy.

Authors:  Patrick Chun; Zev A Wainberg
Journal:  Gastrointest Cancer Res       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.